Regeneron Pharmaceuticals shares owned by Chase Investment Counsel Corp.
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Chase Investment Counsel Corp.
from 13F filings
Historical chart of Chase Investment Counsel Corp. investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Chase Investment Counsel Corp. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Chase Investment Counsel Corp.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $584k | 607 | 962.11 |
| 2022-06-30 | $471k | 798 | 590.23 |
| 2022-03-31 | $557k | 798 | 698.00 |
| 2021-12-31 | $503k | 798 | 630.33 |
| 2020-12-31 | $775k | 1.6k | 482.57 |
| 2020-09-30 | $3.0M | 5.3k | 559.60 |
| 2020-06-30 | $3.6M | 5.8k | 623.52 |
| 2020-03-31 | $3.5M | 7.2k | 488.26 |
More positions owned by Chase Investment Counsel Corp.
View all positions for Chase Investment Counsel Corp.